论文部分内容阅读
目的介绍甲氨蝶呤联合米非司酮保守治疗异位妊娠临床疗效。方法选择136例符合保守治疗异位妊娠患者分为两组,观察组70例采用甲氨蝶呤20mg肌内注射,1次/d,连用5d为一疗程,联合米非司酮50mg口服,每12小时一次,连用5d,对照组66例,采用甲氨蝶呤20mg肌内注射,1次/d,5d,观察两组治疗成功率,对二种治疗方案进行比较。结果观察组成功率92.9%,对照组成功率74.2%,观察组成功率明显高于对照组(P<0.05)。结论甲氨蝶呤联合米非司酮治疗异位妊娠效果满意,用法简便,提高药物保守治疗成功率,减轻了患者的痛苦及经济负担,值得临床推广。
Objective To introduce the clinical efficacy of methotrexate combined with mifepristone in conservative treatment of ectopic pregnancy. Methods 136 cases of patients with conservative treatment of ectopic pregnancy were divided into two groups, the observation group of 70 patients with methotrexate 20mg intramuscular injection, 1 / d, once every 5d for a course of treatment, combined with mifepristone 50mg orally, each Once every 12 hours, once daily for 5 days, and control group of 66 cases. Methotrexate 20mg was intramuscularly injected once a day for 5 days. The success rate of two groups was observed and the two treatment regimens were compared. Results The success rate of the observation group was 92.9%, while that of the control group was 74.2%. The success rate of the observation group was significantly higher than that of the control group (P <0.05). Conclusion Methotrexate combined with mifepristone treatment of ectopic pregnancy satisfactory results, easy to use, to improve the success rate of conservative treatment of drugs, reducing the patient’s suffering and financial burden, worthy of clinical promotion.